Sensitivity Analysis for Trials with Irregular and Informative Assessment Times: Marginal Mean Models and Sensitivity Parameter Selection

arXiv:2610.25454 · stat.ME · Submitted 2026-10-18 · Read on arXiv

Listen

Radio episode about this paper

Transcript

Introduction to the show: ident: Statistics. The day in statistics: methods, theory and the inference under them.

Tom: I'm Tom.

Jane: And I'm Jane, here with Lu, Meng and our in-house large language model, Lalam.

Tom: We're looking at the paper: "Sensitivity Analysis for Trials with Irregular and Informative Assessment Times".

Jane: Here's the gist of the paper. In randomized trials, outcome assessment times often vary across participants and may depend on the underlying outcome process, so outcomes observed near a target time need not represent the target population.

Tom: Whether assessment is informative cannot be determined from the observed data alone.

Jane: The paper extends the sensitivity analysis framework of Smith et al.

Tom: (2024), which is anchored in an explainable assessment assumption and was restricted to continuous outcomes through an identity-link marginal mean model, to a broader class of link functions that accommodates binary and count outcomes.

Title and authors: Jane: It’s about how we can handle situations where people in a trial are assessed at different times, and those assessment times might be informative. It extends some earlier work that focused on continuous outcomes to handle things like binary or count data too.

Tom: So, so it deals with the messiness of assessment timing and making sure our results aren't just capturing timing differences instead of actual treatment effects.

Lu: Exactly, and the authors are extending a framework from Smith et al. two thousand twenty-four that was originally for continuous outcomes using an identity-link marginal mean model to a broader class of link functions that handles binary and count data too <ref:2610.25454#pg1>.

Meng: So they're trying to make the sensitivity analysis robust enough to be used on real-world trial data, not just smooth mathematical models.

Lalam: And they develop this influence function based augmented inverse intensity weighted estimator which is root-n consistent under standard regularity conditions, which is pretty solid for estimation.

The paper's summary: Jane: So what does the paper actually propose? It sets up some assumptions, like the tilting assumption and the generalized marginal mean assumption, to define how we model these irregular assessment times.

Tom: It assumes that for every time t where we see an assessment happening, the distribution of outcomes changes in a specific way relative to the underlying population distribution at that time.

Lu: Specifically, they use a single-index model for the outcome process and an Andersen-Gill model stratified by assessment number to model how often we see someone assessed.

Meng: That sounds like a lot of modeling layered on top of each other, trying to separate the effect of the treatment from the effect of when you got your blood drawn.

Lalam: They then develop these influence functions for the parameter beta and their weighted estimators, which are derived by estimating conditional mean outcomes and computing estimated inverse intensity weights.

The paper's improvements: Tom: So what’s the real improvement here? It’s not just a new estimator; it’s this data driven procedure for selecting the sensitivity parameter.

Jane: They define a true range for the sensitivity parameter alpha, from alpha l to alpha u, by looking at when expected outcomes are above and below some target mean outcome.

Lu: And they use optimization problems and bias corrected via multiplier bootstrap procedures to estimate those bounds, which accounts for uncertainty in selecting that parameter range itself.

Meng: That’s smart because it means we don't just pick a sensitivity number blindly; we find the plausible range based on what the data suggests about the target mean outcome.

Lalam: Then they build a ninety-five percent confidence set for that entire range using either a basic bootstrap or a Wald CI based on those bias corrected point estimates and variance estimators.

Conclusion: Tom: So to wrap up, this paper addresses the core problem of how to analyze trials when assessment times are irregular and informative, and it does so by generalizing the framework to handle binary and count outcomes too.

Jane: It provides a data driven way to select a plausible range for that sensitivity parameter alpha, giving us confidence sets for that range based on the target mean outcome bounds.

Lu: The simulation studies show that even when we violate the explainable assessment assumption, the augmented inverse intensity weighted estimator still performs well and shows smaller bias than original estimators as sample size increases.

Meng: It's good to know it works better under realistic, informative scenarios for our deployment concerns because it suggests the confidence intervals are more reliable than basic bootstrap ones in some cases.

Lalam: Overall, the results for both outcomes indicate that when alpha l and alpha u are similar with a difference no more than zero point eight, there is insufficient evidence to conclude a treatment effect at either follow-up time. When alpha l is greater than alpha u plus zero point eight, the analyses frequently provide evidence that the home visits intervention improves the population mean asthma control outcome relative to portal training alone at both six and twelve months.

Tom: That’s a really concrete finding, linking the sensitivity parameter directly to whether we see a treatment effect or not based on those bounds.

Jane: It shows that when we allow for different informativeness mechanisms between arms, statistically significant treatment effects can emerge under some plausible sensitivity parameter values.

Lu: It broadens the scope substantially by accommodating continuous, binary, and count outcomes through appropriate link functions.

Meng: For us in production, it means we have a principled way to quantify the uncertainty when clinical experts give us ranges for outcome means.

Department of Statistics, North Carolina State University · Department of Oncology, Johns Hopkins School of Medicine · Department of Biostatistics, Bloomberg School of Public Health, Johns Hopkins University · Department of Internal Medicine, University of Utah School of Medicine · Department of Medicine, University of Pennsylvania Perelman School of Medicine

stat.ME

Submitted: 2026-10-18

Updated: 2026-10-29

License: http://arxiv.org/licenses/nonexclusive-distrib/1.0/

Importance score: 92/100

The gist: In randomized trials, outcome assessment times often vary across participants and may depend on the underlying outcome process, so outcomes observed near a target time need not represent the target

Terminology

Summary

In randomized trials, outcome assessment times often vary across participants and may depend on the underlying outcome process, so outcomes observed near a target time need not represent the target population. Whether assessment is informative cannot be determined from the observed data alone. The paper extends the sensitivity analysis framework of Smith et al. (2024), which is anchored in an explainable assessment assumption and was restricted to continuous outcomes through an identity-link marginal mean model, to a broader class of link functions that accommodates binary and count outcomes. Within this framework, it develops an influence function-based augmented inverse intensity-weighted estimator that is root-n consistent under standard regularity conditions. It also proposes a data-driven procedure for selecting the range of the sensitivity parameter from plausible bounds on the target mean outcome and for constructing a confidence set for this range, which accounts for uncertainty in sensitivity parameter selection. The method is illustrated with data from the ARC study and evaluated in simulation studies.

The framework involves:

Assumption 1 (Tilting assumption): For each time t such that λt O(t) > 0, dF y(t) ∆N(t) = 0, O(t) = dF y(t) ∆N(t) = 1, O(t) exp[αy(t)]/c n O(t); αo 0 such that, for all t in [t1, t2], ρt O(t), Y (t) > c for all values of Y (t) and O(t).

Assumption 3 (Generalized marginal mean assumption): For all t in [t1, t2], µ(t) = s s B(t)'β, where B(t) = (B1(t), · · ·, Bp(t))' is a specified vector of basis functions such that R t2 t=t1 B(t)B(t)'dt is positive definite, s ∈ C2 is a known inverse link function with strictly positive derivative ∂s(z)/∂z > 0, and β ∈ R p is a parameter vector.

Assumption 4 (Non-future dependence assumption): Let L = Y (t), X(t): 0 ≤ t ≤ τ. Then limϵ→0+ h P N(t +ϵ) − N(t−) = 1 O(t), L /ϵi = limϵ→0+ h P N(t +ϵ) − N(t−) = 1 O(t), Y (t)/ϵi.

The estimation procedure involves:

Estimation of the Mean Outcome:

The paper models the intensity function λt O(t) using an Andersen-Gill model stratified by assessment number k, and models dF Y (t) = y(t) ∆N(t) = 1, O(t) using a single-index model. Estimators βb and µb(t) are constructed through steps involving estimating the conditional mean outcome Eb Y (Tik) Oi(Tik), computing the estimated inverse intensity weight ρb Tik Oi(Tik), and solving a system of equations for βb j.

Influence Functions:

The observed-data influence function for β is given by:

φj (O) = Z t2 t=t1 Wj (t; β) h Y (t) − E n Y (t) O(t) o ρn t O(t), Y (t) o dN(t)+Z t2 t=t1 Wj (t; β) h E n Y (t) O(t) o − s B(t)'β i dt where Wj (t; β) has the form:

W1(t; β) = V−1 1 B(t) ∂g(µ)/∂µ, V1 = Z t2 u=t1 B(u)B(u)' du; W2(t; β) = V2 (β−1 B), V2(β) = Z t2 u=t1 B(u)B(u)' ∂s(z)/∂z z=B'(u)'β du.

Sensitivity Parameter Selection:

The true range of the sensitivity parameter αa is defined by the interval (αl a, αu a): Wa = α ∈ [α1 a, α2 a]: min t∈[t1,t2] E Y(t; α) > µla, max t∈[t1,t2] E Y(t; α) < µua. The bounds are estimated using optimization problems and bias-corrected via multiplier bootstrap procedures (Algorithm 2).

Confidence Set Construction:

A 95% confidence set for the range of the sensitivity parameter is constructed using either a Basic Bootstrap CI or a Wald CI based on the bias-corrected point estimates and variance estimators.

The paper applies this method to analyze data from the ARC study, examining both continuous (ACQ score) and binary (AC indicator) outcomes. Simulation studies demonstrate that while finite-sample performance can be challenging, the proposed bias-corrected estimators consistently exhibit smaller bias than original estimators as sample size increases, and Wald confidence intervals often achieve better empirical coverage than basic bootstrap confidence intervals. The analysis suggests that statistically significant treatment effects emerge when informative assessment mechanisms differ between treatment arms.

The key findings regarding the ARC study are:

For the ACQ score:

When assuming α0 = α1, there is insufficient evidence to conclude a treatment effect at either 6 or 12 months for either outcome. However, if α0 = 0 and α1 = −0.8 (implying unobserved ACQ scores tend to be lower than observed scores in the intervention arm), there is evidence that the home visits intervention improves the population mean ACQ score at both 6 and 12 months compared to portal training alone.

For the AC indicator:

If α0 = 0 and α1 = 0.8 (implying unobserved AC indicators tend to be higher than observed values in the intervention arm), there is evidence that portal training alone results in better asthma control than the home visits intervention at both 6 and 12 months.

Overall, when α0 and α1 are similar with a difference no more than 0.8, there is insufficient evidence to conclude a treatment effect at either follow-up time. When α0 > α1 + 0.8, the analyses frequently provide evidence that the home visits intervention improves the population mean asthma control outcome relative to portal training alone at both 6 and 12 months.

The paper concludes by demonstrating that when informative assessment mechanisms are allowed to differ between treatment arms, statistically significant treatment effects emerge under some plausible sensitivity parameter values. It also details a data-driven procedure for identifying plausible ranges of the sensitivity parameters and constructing confidence sets based on the plausible bounds for the target mean outcome. The methodology is extended to accommodate binary and count outcomes through appropriate link functions. The authors note limitations regarding non-future dependence assumptions and informative censoring, suggesting future research directions.

Relevant quotes include:

"We extend the sensitivity analysis framework of Smith et al. (2024), which is anchored in an explainable assessment assumption and was restricted to continuous outcomes through an identity-link marginal mean model, to a broader class of link functions that accommodates binary and count outcomes."

Within this generalized framework, we develop an influence function-based augmented inverse intensity-weighted estimator that is root-n consistent under standard regularity conditions.

"We also propose a data-driven procedure for selecting the sensitivity parameter from plausible bounds on the target mean outcome and for constructing a confidence set for this range, which accounts for uncertainty in sensitivity parameter selection."

"The proposed methodology substantially broadens the scope of the sensitivity analysis framework. Our approach accommodates a broad class of outcome types, including continuous, binary, and count outcomes, through appropriate link functions."

Compared with the previous sensitivity analysis framework of Smith et al. (2024), the proposed methodology substantially broadens the scope of the sensitivity analysis framework.

Our approach accommodates a broad class of outcome types, including continuous, binary, and count outcomes, through appropriate link functions.

We develop a data-driven procedure for identifying plausible ranges of the sensitivity parameters and constructing confidence sets based on the plausible bounds for the target mean outcome.

"The results for both outcomes indicate that when α0 and α1 are similar, with the difference in values no more than 0.8, there is insufficient evidence to conclude a treatment effect at either follow-up time. In contrast, when α0 > α1 + 0.8, the analyses frequently provide evidence that the home visits intervention improves the population mean asthma control outcome relative to portal training alone at both 6 and 12 months."

"Overall, the results for both outcomes indicate that when α0 and α1 are similar, with the difference in values no more than 0.8, there is insufficient evidence to conclude a treatment effect at either follow-up time. In contrast, when α0 > α1 + 0.8, the analyses frequently provide evidence that the home visits intervention improves the population mean asthma control outcome relative to portal training alone at both 6 and 12 months."

"In contrast, for the AC indicator, if we assume α0 = 0 and α1 = 0.

Improvements for AI systems

  1. Sensitivity analysis for treatment effect estimation can be generalized to binary and count outcomes by extending frameworks from Smith et al. (2024) beyond continuous outcomes through a broader class of link functions. This allows AI systems to perform more accurate inference when dealing with non-normal data types, such as the ACQ score or asthma control indicator mentioned in the ARC study.

  2. Development of an influence function based augmented inverse intensity-weighted estimator provides a flexible semiparametric modeling approach that achieves root-n consistency under standard regularity conditions. This enables AI systems to estimate treatment effects at clinically meaningful target times even when assessment patterns are irregular and outcomes are informative, addressing limitations in existing methods like inverse intensity weighting.

  3. A data driven procedure for selecting the range of the sensitivity parameter from plausible bounds on the target mean outcome allows AI systems to construct confidence sets for this range, accounting for uncertainty in parameter selection. This provides a principled way to quantify uncertainty when clinical experts provide prior ranges for outcome means, leading to more interpretable sensitivity analysis results.

  4. The proposed estimation procedure for the treatment effect at time t involves estimating intensity functions using an Andersen-Gill model stratified by assessment number and conditional distributions using a single-index model. This allows AI systems to account for informative assessment times by modeling both the assessment process and outcome distribution separately, which is crucial when outcomes are not observed at target times.

  5. The framework enables inference for treatment effects under a range of plausible assumptions, providing a more comprehensive representation of the overall uncertainty in study conclusions compared to methods that rely on single assumptions. This multi-assumption approach allows AI systems to quantify how different informativeness mechanisms affect treatment effect estimates across various outcome types and time points.

  6. The simulation studies demonstrate that the proposed augmented inverse intensity-weighted estimator achieves satisfactory coverage performance, even when the explainable assessment assumption is violated. This suggests that AI models can be trained and validated using this method to ensure their reported confidence intervals accurately reflect true coverage rates under realistic, informative assessment scenarios.

Related papers